The 35th CINP World Congress of Neuropsychopharmacology

講演情報

[CINP2024] Spotlight Session

CINP2024 » Spotlight Session

Spotlight Session 1
Neuroscience-based Nomenclature (NbN) and Precision in Psychopharmacology

2024年5月24日(金) 13:30 〜 14:30 Room 5 (G409)

Chair: Joseph Zohar (National Post-Trauma Center, Research Foundation by the Sheba Medical Center, Israel)

Symposium outline:
One of the biggest challenges facing clinicians and researchers is to be precise in the medications they use. Our current nomenclature, which is disease-based, uses the terms "antidepressants" and "antipsychotics" (including "second generation" antipsychotics) "mood stabilizers","anxiolytics" etc., which does not do justice to the wealth of neuroscience knowledge that has been accumulated in the past 60 years, since these terms were initially coined.
Prof. Zohar will open the symposia by introducing the growing interest in NbN in the scientific arena, as well as providing a practical demonstration of how to use the search engine of NbN. In the second talk, Prof. Blier will help us dive deeper into the potential of moving to pharmacologically driven concepts by illustrating how taking into consideration the dose of the medication has clear clinical implications in practice and research. In the third talk, Prof. Correll will talk about how using NbN can help to make updated, precise pharmacological steps in the treatment of psychosis. Finally, Dr. Seker will bring the early career voices on NbN from different perspectives, including the perception of the scientific basis for informed prescribing.
In this symposium, there will be ample time for Q&A, which will be led by Prof. Zohar.

[SS1-4]

*Joseph Zohar1 (1. National Post-Trauma Center, Research Foundation by the Sheba Medical Center, Israel)

抄録パスワード認証
抄録の閲覧にはパスワードが必要です。パスワードを入力して認証してください。

パスワード